Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STUART CHALEW

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1558384594
CMS profile
24623
Location
NEW ORLEANS, LA

General Payments · PY2018–2024

$6,942.47

  • Reported across 109 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$459.71

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $459.71 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $374.51 16
PY2019 $445.09 18
PY2020 $1,463.25 13
PY2021 $3,390.09 15
PY2022 $403.74 16
PY2023 $406.08 14
PY2024 $459.71 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.14 07/05/2024 Food and Beverage Undisputed 01/23/2026 1125123453 CMS
Ascendis Pharma Inc $29.88 01/18/2024 Food and Beverage Undisputed 01/23/2026 1133843386 CMS
Ascendis Pharma Inc $23.45 05/21/2024 Food and Beverage Undisputed 01/23/2026 1133845162 CMS
Ascendis Pharma Inc $28.12 09/11/2024 Food and Beverage Undisputed 01/23/2026 1133847482 CMS
Azurity Pharmaceuticals, Inc. $17.76 10/08/2024 Food and Beverage Undisputed 01/23/2026 1134004049 CMS
BETA BIONICS, INC. $16.40 04/08/2024 Food and Beverage Undisputed 01/23/2026 1087875635 CMS
BioMarin Pharmaceutical Inc. $25.65 02/20/2024 Food and Beverage Undisputed 01/23/2026 1127060017 CMS
Chiesi USA, Inc. $27.20 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151802912 CMS
Dexcom, Inc. $17.61 08/13/2024 Food and Beverage Undisputed 01/23/2026 1153338733 CMS
Dexcom, Inc. $22.17 10/15/2024 Food and Beverage Undisputed 01/23/2026 1153338735 CMS
Kyowa Kirin, Inc. $110.48 03/06/2024 Food and Beverage Undisputed 01/23/2026 1127043839 CMS
Medtronic, Inc. $14.55 09/17/2024 Food and Beverage Undisputed 01/23/2026 1119374074 CMS
Neurocrine Biosciences, Inc. $24.66 11/12/2024 Food and Beverage Undisputed 01/23/2026 1150840980 CMS
Novo Nordisk Inc $20.53 07/30/2024 Food and Beverage Undisputed 01/23/2026 1096951508 CMS
PFIZER INC. $17.57 03/19/2024 Food and Beverage Undisputed 01/23/2026 1131271044 CMS
PFIZER INC. $25.50 07/16/2024 Food and Beverage Undisputed 01/23/2026 1131762016 CMS
SANOFI-AVENTIS U.S. LLC $19.04 12/03/2024 Food and Beverage Undisputed 01/23/2026 1139946005 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.